Samuel Kesse

807 total citations
22 papers, 613 citations indexed

About

Samuel Kesse is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Samuel Kesse has authored 22 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomaterials, 6 papers in Biomedical Engineering and 5 papers in Molecular Biology. Recurrent topics in Samuel Kesse's work include Nanoparticle-Based Drug Delivery (5 papers), Graphene and Nanomaterials Applications (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Samuel Kesse is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Graphene and Nanomaterials Applications (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Samuel Kesse collaborates with scholars based in China, Australia and Pakistan. Samuel Kesse's co-authors include Kofi Oti Boakye‐Yiadom, Muhammad Asim Farooq, Md Aquib, Mensura Sied Filli, Yaw Opoku‐Damoah, Faisal Raza, Bo Wang, Rohit Bavi, Bo Wang and Daulat Haleem Khan and has published in prestigious journals such as Molecules, International Journal of Pharmaceutics and Nano Today.

In The Last Decade

Samuel Kesse

20 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Kesse China 11 278 214 189 153 47 22 613
Mensura Sied Filli China 8 273 1.0× 180 0.8× 154 0.8× 131 0.9× 32 0.7× 11 496
Ajinkya Nitin Nikam India 15 208 0.7× 355 1.7× 206 1.1× 175 1.1× 42 0.9× 27 779
Asifkhan Shanavas India 17 338 1.2× 284 1.3× 170 0.9× 116 0.8× 35 0.7× 46 654
Legha Ansari Iran 15 285 1.0× 279 1.3× 251 1.3× 236 1.5× 28 0.6× 22 742
Jalil Charmi Iran 13 194 0.7× 331 1.5× 269 1.4× 197 1.3× 39 0.8× 17 637
Shanid Mohiyuddin India 11 322 1.2× 174 0.8× 134 0.7× 82 0.5× 26 0.6× 14 537
Chen‐Lun Liu Taiwan 13 288 1.0× 284 1.3× 208 1.1× 147 1.0× 45 1.0× 24 633
Gasper Fernandes India 13 148 0.5× 209 1.0× 115 0.6× 131 0.9× 78 1.7× 20 554
Liyao Luo China 16 225 0.8× 476 2.2× 353 1.9× 287 1.9× 52 1.1× 26 777
Rajesh R. Kulkarni United States 6 485 1.7× 301 1.4× 242 1.3× 157 1.0× 20 0.4× 11 874

Countries citing papers authored by Samuel Kesse

Since Specialization
Citations

This map shows the geographic impact of Samuel Kesse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Kesse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Kesse more than expected).

Fields of papers citing papers by Samuel Kesse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Kesse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Kesse. The network helps show where Samuel Kesse may publish in the future.

Co-authorship network of co-authors of Samuel Kesse

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Kesse. A scholar is included among the top collaborators of Samuel Kesse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Kesse. Samuel Kesse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kesse, Samuel, Yuhong Xu, Miao He, et al.. (2024). MDSC-targeted liposomal all-trans retinoic acid suppresses mMdscs and improves immunotherapy in HBV infection. Expert Opinion on Drug Delivery. 21(2). 347–363. 1 indexed citations
3.
Yuan, Zheng, Yang Yang, Miao He, et al.. (2024). Targeted counteracting of overactive macrophages by melittin stable-loaded solid lipid nanoparticles alleviates cytokine storm and acute inflammatory injury. Biomedicine & Pharmacotherapy. 179. 117371–117371. 5 indexed citations
5.
Boafo, George Frimpong, Yejiao Shi, Qingqing Xiao, et al.. (2022). Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes. Chinese Chemical Letters. 33(10). 4600–4604. 38 indexed citations
6.
Filli, Mensura Sied, Samuel Kesse, Md Aquib, et al.. (2022). Synthetic berberine derivatives as potential new drugs. Brazilian Journal of Pharmaceutical Sciences. 58. 11 indexed citations
7.
Wei, Xing & Samuel Kesse. (2021). Heterogeneously Integrated Photonic Chip on Lithium Niobate Thin-Film Waveguide. Crystals. 11(11). 1376–1376. 1 indexed citations
8.
Aquib, Md, Hang Zhang, Faisal Raza, et al.. (2021). Delivery of repurposed disulfiram by aminated mesoporous silica nanoparticles for anticancer therapy. Journal of Molecular Liquids. 346. 117065–117065. 10 indexed citations
9.
Boakye‐Yiadom, Kofi Oti, Samuel Kesse, Md Aquib, et al.. (2020). Solid dispersion systems engineered from hydroxypropyl‐β‐cyclodextrin and water‐soluble polymers for enhanced oral bioavailability of nimodipine. Polymers for Advanced Technologies. 31(10). 2270–2278. 3 indexed citations
10.
Farooq, Muhammad Asim, Hanitrarimalala Veroniaina, Mensura Sied Filli, et al.. (2020). Food Protein-Based Nanodelivery Systems for Hydrophobic and Poorly Soluble Compounds. AAPS PharmSciTech. 21(3). 101–101. 13 indexed citations
11.
Kesse, Samuel, Kofi Oti Boakye‐Yiadom, Yaw Opoku‐Damoah, et al.. (2019). Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery. Pharmaceutics. 11(2). 77–77. 77 indexed citations
12.
Kesse, Samuel, et al.. (2019). Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems. Molecules. 24(20). 3805–3805. 27 indexed citations
14.
Filli, Mensura Sied, Md Aquib, Kofi Oti Boakye‐Yiadom, et al.. (2019). THE IMPACT OF PHYSICOCHEMICAL CHARACTERISTICS ON THERAPEUTIC EFFICACY OF ANTICANCER NANOMATERIALS: A REVIEW. International Journal of Pharmaceutical Sciences and Drug Research. 61–70. 7 indexed citations
15.
Boakye‐Yiadom, Kofi Oti, Samuel Kesse, Yaw Opoku‐Damoah, et al.. (2019). Carbon dots: Applications in bioimaging and theranostics. International Journal of Pharmaceutics. 564. 308–317. 231 indexed citations
16.
Sarkodie, Emmanuel Konadu, et al.. (2019). Nanomedicinal delivery systems for intelligent treatment of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology. 53. 101152–101152. 2 indexed citations
17.
Farooq, Muhammad Asim, Md Aquib, Daulat Haleem Khan, et al.. (2019). Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview. Artificial Cells Nanomedicine and Biotechnology. 47(1). 1674–1692. 96 indexed citations
18.
Tao, Tao, Md Aquib, Samuel Kesse, et al.. (2019). Injectable hydrogels for targeted delivering of therapeutic molecules for tissue engineering and disease treatment. Polymers for Advanced Technologies. 31(2). 192–203. 9 indexed citations
19.
Wan, Xinyu, et al.. (2018). Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes. Molecules. 23(7). 1757–1757. 11 indexed citations
20.
Afriyie, Daniel Kwame, Seth Kwabena Amponsah, Samuel Kesse, et al.. (2017). A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications. Hospital Practice. 45(4). 143–149. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026